Benzinga's Top Downgrades

by Lisa Levin, Benzinga Editor

December 30, 2013 9:38 AM | 20 seconds read | Make a Comment

Analysts at Ascendiant downgraded POZEN

POZN

from “strong buy” to “neutral.” The target price for POZEN is set to $10. POZEN's shares closed at $9.77 on Friday. JMP Securities downgraded Myriad Genetics

MYGN

from “market perform” to “underperform.” The target price for Myriad Genetics is set to $15. Myriad Genetics' shares closed at $24.14 on Friday.

Market News and Data brought to you by Benzinga APIs

Posted In: Downgrades Analyst Ratings Top Downgrades

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Benzinga's Top Downgrades